Diligence memo · auto-generated · as of July 2, 2026
TissueMill Technologies LLC
TissueMill Technologies LLC looks over-valued against its niche peers and is dormant on financing cadence.
Businessfiled
TissueMill Technologies LLC operates in Biotechnology, based in SYOSSET.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
TissueMill Technologies LLC has raised $1.0M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).
Largest single filing: $1.0M on 2022-04-14.
Most recent recorded round closed around 2022-04-14.
Valuation (modeled)modeled
Provath models TissueMill Technologies LLC at approximately $18M (range $533K–$120M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Over-valued. Modeled value is 5.66× the median modeled value of Pre-Seed Biotechnology companies in 2022–2024 (185 peers) — value vs value, same stage and era. Issuer reports no revenue, yet is modeled well above niche peers.
Financing rhythm & timingmixed
Last raise 4.2 yr ago; this sector typically re-raises about every 14 months.
Only one round on record and long silent — often defunct, acquired, or gone quiet.
Comparablesmixed
Capital scale ranks ahead of 19% of Biotechnology peers (4293 compared).
Modeled value ranks above 27% of those peers.
Closest niche peers: Aldebaran Therapeutics, Inc., BullFrog AI Holdings, Inc., Vesicle Therapeutics Inc., TAUC3 Biologics Ltd, UCHU Biosensors, Inc..
Peoplefiled
1 named person on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
Modeled above niche peers — valuation risk on entry.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.